XML 30 R18.htm IDEA: XBRL DOCUMENT v3.22.2
Segment Information
 6 Months Ended
Jun. 30, 2022
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION
As previously disclosed, effective December 31, 2021 we changed our reportable business segments to (i) MedSurg and Neurotechnology and (ii) Orthopaedics and Spine to align to our new internal reporting structure. We have reflected these changes in all historical periods presented.
Three MonthsSix Months
2022202120222021
MedSurg and Neurotechnology$2,549 $2,359 $4,972 $4,550 
Orthopaedics and Spine1,944 1,935 3,796 3,697 
Net sales$4,493 $4,294 $8,768 $8,247 
MedSurg and Neurotechnology$601 $702 $1,212 $1,337 
Orthopaedics and Spine607 563 1,129 1,018 
Segment operating income$1,208 $1,265 $2,341 $2,355 
Items not allocated to segments:
Corporate and other
$(145)$(154)$(344)$(316)
Acquisition and integration-related costs(37)(120)(186)(369)
Amortization of intangible assets
(160)(149)(310)(330)
Restructuring-related and other charges
(62)(17)(171)(31)
Medical device regulations
(32)(26)(60)(45)
Recall-related matters
(4)(76)(18)(82)
Regulatory and legal matters
4 9 (33)9 
Consolidated operating income$772 $732 $1,219 $1,191 
There were no significant changes to total assets by segment from information provided in our Annual Report on Form 10-K for 2021, other than the addition of the assets acquired in the Vocera acquisition which are included in the MedSurg and Neurotechnology segment.